• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 与人血管紧张素转化酶 2 受体热点残基相互作用的结构与模拟分析。

Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor.

机构信息

Department of Biotechnology, Koneru Lakshmaiah Education Foundation (KLEF), Guntur, India.

Institute of Health and Sport, Victoria University, Melbourne, Australia.

出版信息

J Biomol Struct Dyn. 2021 Jul;39(11):4015-4025. doi: 10.1080/07391102.2020.1773318. Epub 2020 Jun 4.

DOI:10.1080/07391102.2020.1773318
PMID:32448098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7284149/
Abstract

The novel corona virus disease 2019 (SARS-CoV 2) pandemic outbreak was alarming. The binding of SARS-CoV (CoV) spike protein (S-Protein) Receptor Binding Domain (RBD) to Angiotensin converting enzyme 2 (ACE2) receptor initiates the entry of corona virus into the host cells leading to the infection. However, considering the mutations reported in the SARS-CoV 2 (nCoV), the structural changes and the binding interactions of the S-protein RBD of nCoV were not clear. The present study was designed to elucidate the structural changes, hot spot binding residues and their interactions between the nCoV S-protein RBD and ACE2 receptor through computational approaches. Based on the sequence alignment, a total of 58 residues were found mutated in nCoV S-protein RBD. These mutations led to the structural changes in the nCoV S-protein RBD 3d structure with 4 helices, 10 sheets and intermittent loops. The nCoV RBD was found binding to ACE2 receptor with 11 hydrogen bonds and 1 salt bridge. The major hot spot amino acids involved in the binding identified by interaction analysis after simulations includes Glu 35, Tyr 83, Asp 38, Lys 31, Glu 37, His 34 amino acid residues of ACE2 receptor and Gln 493, Gln 498, Asn 487, Tyr 505 and Lys 417 residues in nCoV S-protein RBD. Based on the hydrogen bonding, RMSD and RMSF, total and potential energies, the nCoV was found binding to ACE2 receptor with higher stability and rigidity. Concluding, the hotspots information will be useful in designing blockers for the nCoV spike protein RBD. [Formula: see text]Communicated by Ramaswamy H. Sarma.

摘要

新型冠状病毒病 2019(SARS-CoV-2)大流行疫情令人震惊。SARS-CoV(CoV)刺突蛋白(S-蛋白)受体结合域(RBD)与血管紧张素转化酶 2(ACE2)受体的结合启动了冠状病毒进入宿主细胞,导致感染。然而,考虑到报道的 SARS-CoV-2(nCoV)中的突变,nCoV S-蛋白 RBD 的结构变化和结合相互作用尚不清楚。本研究旨在通过计算方法阐明 nCoV S-蛋白 RBD 与 ACE2 受体之间的结构变化、热点结合残基及其相互作用。基于序列比对,共发现 nCoV S-蛋白 RBD 中有 58 个残基发生突变。这些突变导致 nCoV S-蛋白 RBD 3d 结构的结构变化,该结构有 4 个螺旋、10 个片层和间歇性环。nCoV RBD 被发现与 ACE2 受体结合有 11 个氢键和 1 个盐桥。通过模拟后相互作用分析确定的结合中的主要热点氨基酸包括 ACE2 受体中的 Glu35、Tyr83、Asp38、Lys31、Glu37 和 His34 氨基酸残基,以及 nCoV S-蛋白 RBD 中的 Gln493、Gln498、Asn487、Tyr505 和 Lys417 氨基酸残基。基于氢键、RMSD 和 RMSF、总能量和势能,nCoV 与 ACE2 受体的结合更稳定和刚性。总之,热点信息将有助于设计针对 nCoV 刺突蛋白 RBD 的阻断剂。[公式:见文本]由 Ramaswamy H. Sarma 传达。

相似文献

1
Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor.SARS-CoV-2 与人血管紧张素转化酶 2 受体热点残基相互作用的结构与模拟分析。
J Biomol Struct Dyn. 2021 Jul;39(11):4015-4025. doi: 10.1080/07391102.2020.1773318. Epub 2020 Jun 4.
2
Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.突变对人 SARS-CoV-2 受体结合域与宿主细胞受体 ACE2 结构、功能和动力学的影响:分子动力学模拟研究。
J Biomol Struct Dyn. 2021 Nov;39(18):7231-7245. doi: 10.1080/07391102.2020.1802348. Epub 2020 Aug 7.
3
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.新型冠状病毒受体识别:基于 SARS 冠状病毒长达十年结构研究的分析。
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.00127-20.
4
Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.探究 SARS-CoV-2 P.1 变体刺突蛋白与人 ACE2 受体增强结合的结构基础。
J Cell Biochem. 2022 Jul;123(7):1207-1221. doi: 10.1002/jcb.30276. Epub 2022 May 27.
5
An approach to identify the potential hot spots in SARS-CoV-2 spike RBD to block the interaction with ACE2 receptor.一种鉴定 SARS-CoV-2 刺突 RBD 中潜在热点以阻断与 ACE2 受体相互作用的方法。
J Biomol Struct Dyn. 2022 Oct;40(16):7408-7423. doi: 10.1080/07391102.2021.1897682. Epub 2021 Mar 9.
6
Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.SARS-CoV-2 刺突受体结合域的突变景观和计算机结构模型揭示了病毒-宿主相互作用的关键分子决定因素。
BMC Mol Cell Biol. 2022 Jan 7;23(1):2. doi: 10.1186/s12860-021-00403-4.
7
Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).抑制 S 蛋白 RBD 和 hACE2 相互作用以控制 SARS-CoV-2 感染(COVID-19)。
Mini Rev Med Chem. 2021;21(6):689-703. doi: 10.2174/1389557520666201117111259.
8
Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2.木犀草素抑制严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突蛋白与血管紧张素转化酶 2 的结合。
Phytother Res. 2023 Aug;37(8):3508-3521. doi: 10.1002/ptr.7826. Epub 2023 May 11.
9
Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain/ACE2 Complex*.SARS-CoV-2 受体结合域/ACE2 复合物的计算热点分析*。
Chembiochem. 2021 Apr 6;22(7):1196-1200. doi: 10.1002/cbic.202000562. Epub 2020 Dec 4.
10
Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective.血管紧张素转化酶 2(ACE2)与严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)刺突受体结合域(RBD)的相互作用:结构视角。
Mol Biol Rep. 2023 Mar;50(3):2713-2721. doi: 10.1007/s11033-022-08193-4. Epub 2022 Dec 23.

引用本文的文献

1
Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry.人ACE2中与SARS-CoV-2刺突蛋白结合及病毒进入相关的关键氨基酸残基。
Microbiol Spectr. 2025 Jun 20:e0324424. doi: 10.1128/spectrum.03244-24.
2
Molecular docking, pharmacological profiling, and MD simulations of glycolytic inhibitors targeting novel SARS CoV-2 main protease and spike protein.针对新型冠状病毒2型主要蛋白酶和刺突蛋白的糖酵解抑制剂的分子对接、药理学分析及分子动力学模拟
In Silico Pharmacol. 2025 Mar 14;13(1):44. doi: 10.1007/s40203-025-00336-2. eCollection 2025.
3
Transformation of peptides to small molecules in medicinal chemistry: Challenges and opportunities.药物化学中肽向小分子的转化:挑战与机遇
Acta Pharm Sin B. 2024 Oct;14(10):4243-4265. doi: 10.1016/j.apsb.2024.06.019. Epub 2024 Jun 25.
4
Cervids ACE2 Residues that Bind the Spike Protein can Provide Susceptibility to SARS-CoV-2.鹿科动物 ACE2 残基与刺突蛋白结合可使 SARS-CoV-2 易感。
Ecohealth. 2023 Mar;20(1):9-17. doi: 10.1007/s10393-023-01632-z. Epub 2023 Apr 27.
5
Identifying promising druggable binding sites and their flexibility to target the receptor-binding domain of SARS-CoV-2 spike protein.鉴定有前景的可成药结合位点及其靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白受体结合域的灵活性。
Comput Struct Biotechnol J. 2023;21:2339-2351. doi: 10.1016/j.csbj.2023.03.029. Epub 2023 Mar 18.
6
Pharmacoinformatic approach to identify potential phytochemicals against SARS-CoV-2 spike receptor-binding domain in native and variants of concern.采用药物信息学方法鉴定针对 SARS-CoV-2 刺突受体结合域的潜在植物化学物质,包括本地株和关注变异株。
Mol Divers. 2023 Dec;27(6):2741-2766. doi: 10.1007/s11030-022-10580-9. Epub 2022 Dec 22.
7
Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach. Toll 样受体在 SARS-CoV-2 中的作用:一种治疗方法。
Int J Mol Sci. 2022 Sep 14;23(18):10716. doi: 10.3390/ijms231810716.
8
Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein.突变信息学:刺突蛋白的 SARS-CoV-2 受体结合域。
Drug Discov Today. 2022 Oct;27(10):103312. doi: 10.1016/j.drudis.2022.06.012. Epub 2022 Jul 3.
9
Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor.棕榈酰乙醇酰胺(PEA)通过与 S 蛋白和 ACE-2 受体相互作用抑制 SARS-CoV-2 进入。
Viruses. 2022 May 17;14(5):1080. doi: 10.3390/v14051080.
10
Native, engineered and de novo designed ligands targeting the SARS-CoV-2 spike protein.靶向 SARS-CoV-2 刺突蛋白的天然、工程和从头设计配体。
Biotechnol Adv. 2022 Oct;59:107986. doi: 10.1016/j.biotechadv.2022.107986. Epub 2022 May 19.